180 Life Sciences Corp (ATNF)
1.62
+0.01
(+0.62%)
USD |
NASDAQ |
May 31, 16:00
1.63
+0.01
(+0.62%)
After-Hours: 20:00
180 Life Sciences Net Income (Quarterly): -1.070M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.070M |
December 31, 2023 | -1.227M |
September 30, 2023 | -10.27M |
June 30, 2023 | -3.680M |
March 31, 2023 | -4.762M |
December 31, 2022 | -21.74M |
September 30, 2022 | -21.49M |
June 30, 2022 | 2.939M |
March 31, 2022 | 1.564M |
December 31, 2021 | 1.036M |
Date | Value |
---|---|
September 30, 2021 | 18.30M |
June 30, 2021 | -23.46M |
March 31, 2021 | -16.20M |
December 31, 2020 | -7.941M |
September 30, 2020 | -0.8294M |
June 30, 2020 | 0.2674M |
March 31, 2020 | -2.381M |
December 31, 2019 | -25.59M |
September 30, 2019 | -0.0218M |
June 30, 2019 | -0.0108M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-25.59M
Minimum
Dec 2019
18.30M
Maximum
Sep 2021
-5.828M
Average
-1.804M
Median
Net Income (Quarterly) Benchmarks
Seelos Therapeutics Inc | -2.664M |
GT Biopharma Inc | -2.266M |
Altimmune Inc | -24.39M |
Oragenics Inc | -2.451M |
MAIA Biotechnology Inc | -8.068M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 2.092M |
EPS Diluted (Quarterly) | -1.68 |
Enterprise Value | 1.638M |
Earnings Yield | -2.58K% |